Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Reduced risk seen for total knee replacement and total hip replacement with metformin use
Reduced risk seen for total knee replacement and total hip replacement with metformin use
Results consistent regardless of pretreatment 25-hydroxyvitamin D levels
More adults receiving IVIG versus placebo had Total Improvement Score of at least 20 at 16 weeks
Only one of 15 muscle symptom-related reports by study participants assigned to statins believed to be due to statins
Visual Analog Scale pain score lower at one, two, three, and five hours postoperatively
Incidence of shoulder conditions per 10,000 vaccinations was 1.22 for adults (age 18 years or older) and 0.05 for children (age 3 to 17 years)
Limited evidence suggests that continuing biological DMARDs may lower risk for disease flares without increasing risk for postop complications
This slideshow shows drug information for Susvimo. Click here for the complete Susvimo monograph.
The ongoing phase 3 BE MOBILE 1 study compared the efficacy and safety of bimekizumab to placebo in adults with active nr-axSpA.
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.